420 related articles for article (PubMed ID: 6260336)
1. Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
Shouval D; Reid LM; Chakraborty PR; Ruiz-Opazo N; Morecki R; Gerber MA; Thung SN; Shafritz DA
Cancer Res; 1981 Apr; 41(4):1342-50. PubMed ID: 6260336
[TBL] [Abstract][Full Text] [Related]
2. Enhanced tumorigenicity and hepatitis B virus genes in a human hepatoma cell line injected into immunosuppressed nude mice.
Shouval D; Ross R; Reid LM; Shafritz DA
Trans Assoc Am Physicians; 1981; 94():154-64. PubMed ID: 6283704
[No Abstract] [Full Text] [Related]
3. Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line.
Huber BE; Dearfield KL; Williams JR; Heilman CA; Thorgeirsson SS
Cancer Res; 1985 Sep; 45(9):4322-9. PubMed ID: 2992777
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B surface antigen and alpha-fetoprotein secreting human primary liver cell cancer in athymic mice.
Bassendine MF; Arborgh BA; Shipton U; Monjardino J; Aranguibel F; Thomas HC; Sherlock S
Gastroenterology; 1980 Sep; 79(3):528-32. PubMed ID: 6159247
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
6. Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro.
Luber B; Arnold N; Stürzl M; Höhne M; Schirmacher P; Lauer U; Wienberg J; Hofschneider PH; Kekulé AS
Oncogene; 1996 Apr; 12(8):1597-608. PubMed ID: 8622879
[TBL] [Abstract][Full Text] [Related]
7. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
8. Tumorigenicity in athymic mice of the human colon carcinoma cell line SW1116 expressing the tumor-associated antigenic determinant CA 19-9.
Klug TL; Salzman S; Quinn A; Melincoff GA; Sedmak DD; Tubbs RR; Zurawski VR
Cancer Res; 1984 Nov; 44(11):5212-8. PubMed ID: 6207914
[TBL] [Abstract][Full Text] [Related]
9. Deletion of integrated hepatitis B virus genome and cellular flanking sequences in hepatocellular carcinoma cells in BALB/c mice.
Chang PC; Hu CP; Chen SH; Wang-Wuu S; Chang C
Hepatology; 1995 Jun; 21(6):1504-9. PubMed ID: 7768493
[TBL] [Abstract][Full Text] [Related]
10. Culturing of human hepatocellular carcinoma. A simple and reproducible method.
Laohathai K; Bhamarapravati N
Am J Pathol; 1985 Feb; 118(2):203-8. PubMed ID: 2578738
[TBL] [Abstract][Full Text] [Related]
11. Immune reactions against hepatitis B viral antigens lead to the rejection of hepatocellular carcinoma in BALB/c mice.
Chen SH; Hu CP; Lee CK; Chang C
Cancer Res; 1993 Oct; 53(19):4648-51. PubMed ID: 8402642
[TBL] [Abstract][Full Text] [Related]
12. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
[TBL] [Abstract][Full Text] [Related]
13. The oncogenic potential of hepatitis B virus rtA181T/ surface truncation mutant.
Lai MW; Yeh CT
Antivir Ther; 2008; 13(7):875-9. PubMed ID: 19043921
[TBL] [Abstract][Full Text] [Related]
14. A serum-free growth of a human hepatoma cell line as a tool for hepatocarcinogenesis and virus gene expression.
Bagnarelli P; Brugia M; Clementi M
Dev Biol Stand; 1985; 60():45-53. PubMed ID: 2995177
[TBL] [Abstract][Full Text] [Related]
15. Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines.
Fujise K; Nagamori S; Hasumura S; Homma S; Sujino H; Matsuura T; Shimizu K; Niiya M; Kameda H; Fujita K
Hepatogastroenterology; 1990 Oct; 37(5):457-60. PubMed ID: 1701409
[TBL] [Abstract][Full Text] [Related]
16. A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma.
Atarashi Y; Yasumura S; Nambu S; Yoshio Y; Murakami J; Takahara T; Higuchi K; Watanabe A; Miyata K; Kato M
Hepatology; 1998 Jul; 28(1):57-67. PubMed ID: 9657097
[TBL] [Abstract][Full Text] [Related]
17. [Effects of tumor suppressing gene TIP30/CC3 on the growth of tumor cells].
Zhang X; Ouyang XN; Li XD; Zhao J; Guo YJ
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):38-41. PubMed ID: 15670490
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].
Li Y; Tang Z; Ye S; Liu Y; Chen J; Xue Q; Huang X; Chen J; Bao W; Yang J; Gao D
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):601-5. PubMed ID: 12133480
[TBL] [Abstract][Full Text] [Related]
19. [Biological effects of COOH-terminal amino acid deletions of hepatitis B virus X protein on hepatocellular carcinoma cell line Huh7].
Liu XH; Zhu MH; Cao XZ; Zheng JM; Chen Y
Ai Zheng; 2005 Oct; 24(10):1213-9. PubMed ID: 16219135
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen and alpha-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model.
Wang ZF; Stein R; Sharkey RM; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):869s-872s. PubMed ID: 1688735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
